High-Throughput Screening Market by Product & Service (Consumables, Instruments, Services), Technology (Cell-Based Assays, Lab-on-a-Chip Technology, Label-Free Technology), Application, End User - Global Forecast 2023-2030
The High-Throughput Screening Market size was estimated at USD 20.37 billion in 2022 and expected to reach USD 23.05 billion in 2023, at a CAGR 13.60% to reach USD 56.53 billion by 2030.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the High-Throughput Screening Market.
- Based on Product & Service, market is studied across Consumables, Instruments, Services, and Software. The Consumables is further studied across Laboratory Equipment and Reagents & Assay Kits. The Instruments is further studied across Detection Systems and Liquid Handling Systems. The Consumables is projected to witness significant market share during forecast period.
- Based on Technology, market is studied across Cell-Based Assays, Lab-on-a-Chip Technology, and Label-Free Technology. The Cell-Based Assays is further studied across 2D Cell Culture, 3D Cell Culture, Perfusion Cell Culture, and Reporter-Based Assays. The 3D Cell Culture is further studied across Scaffold-Based Technology and Scaffold-Free Technology. The Scaffold-Based Technology is further studied across Hydrogels, Inert Matrix & Solid Scaffolds, and Micropatterned Surfaces. The Hydrogels is further studied across Alginate & Agarose, Animal-Derived Hydrogels, and Synthetic Hydrogels. The Animal-Derived Hydrogels is further studied across Collagen and Matrigel. The Scaffold-Free Technology is further studied across Hanging-Drop Plates and Ultra-Low Binding Plates. The Cell-Based Assays is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Biochemical Screening, Drug Discovery, and Life Sciences Research. The Life Sciences Research is projected to witness significant market share during forecast period.
- Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies. The Contract Research Organizations is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the High-Throughput Screening Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape High-Throughput Screening Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the High-Throughput Screening Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Aurora Biomed Inc., AXXAM S.p.A., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BMG LABTECH GmbH, Charles River Laboratories International, Inc., Corning Incorporated, Danaher Corporation, DIANA Biotechnologies, a.s., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Hamilton Company, IRBM S.p.A., Lonza Group AG, Luminex Corporation, Merck KGaA, Molecular Devices, LLC, NanoTemper Technologies GmbH, PerkinElmer, Inc., Promega Corporation, Reprocell Inc., SYGNATURE DISCOVERY LIMITED, Tecan Trading AG, and Thermo Fisher Scientific Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the High-Throughput Screening Market?
- Which products, segments, applications, and areas hold the highest investment potential in the High-Throughput Screening Market?
- What is the competitive strategic window for identifying opportunities in the High-Throughput Screening Market?
- What are the latest technology trends and regulatory frameworks in the High-Throughput Screening Market?
- What is the market share of the leading vendors in the High-Throughput Screening Market?
- Which modes and strategic moves are suitable for entering the High-Throughput Screening Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. High-Throughput Screening Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing adoption of open innovation models in biotechnology and pharmaceutical companies
- 5.1.1.2. Rising applications in stem cell research
- 5.1.2. Restraints
- 5.1.2.1. High cost associated with the equipment procurement and maintenance
- 5.1.3. Opportunities
- 5.1.3.1. Increasing investment in R&D by pharmaceutical & Government authorities
- 5.1.3.2. Technological advancements high throughput screening
- 5.1.4. Challenges
- 5.1.4.1. Dearth of skilled operators coupled with complexities related to data interpretation
- 5.2. Market Segmentation Analysis
- 5.2.1. Product & Service: Proliferating use of software in the HTS process to manage vast amounts of raw data
- 5.2.2. Technology: Adoption of cell-based assay technologies to get biologically relevant data for the drug discovery process
- 5.2.3. Application: Extensive utilization of the HTS process in drug discovery to identify compounds with pharmacological or biological activity
- 5.2.4. End User: Penetration of HTS technology in pharmaceutical & biotechnology companies for rapid development of novel therapeutics
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. High-Throughput Screening Market, by Product & Service
- 6.1. Introduction
- 6.2. Consumables
- 6.3.1. Laboratory Equipment
- 6.3.2. Reagents & Assay Kits
- 6.3. Instruments
- 6.4.1. Detection Systems
- 6.4.2. Liquid Handling Systems
- 6.4. Services
- 6.5. Software
- 7. High-Throughput Screening Market, by Technology
- 7.1. Introduction
- 7.2. Cell-Based Assays
- 7.3.1. 2D Cell Culture
- 7.3.2. 3D Cell Culture
- 7.3.3.1. Scaffold-Based Technology
- 7.3.3.2.1. Hydrogels
- 7.3.3.2.2.1. Alginate & Agarose
- 7.3.3.2.2.2. Animal-Derived Hydrogels
- 7.3.3.2.2.3.1. Collagen
- 7.3.3.2.2.3.2. Matrigel
- 7.3.3.2.2.3. Synthetic Hydrogels
- 7.3.3.2.2. Inert Matrix & Solid Scaffolds
- 7.3.3.2.3. Micropatterned Surfaces
- 7.3.3.2. Scaffold-Free Technology
- 7.3.3.3.1. Hanging-Drop Plates
- 7.3.3.3.2. Ultra-Low Binding Plates
- 7.3.3. Perfusion Cell Culture
- 7.3.4. Reporter-Based Assays
- 7.3. Lab-on-a-Chip Technology
- 7.4. Label-Free Technology
- 8. High-Throughput Screening Market, by Application
- 8.1. Introduction
- 8.2. Biochemical Screening
- 8.3. Drug Discovery
- 8.4. Life Sciences Research
- 9. High-Throughput Screening Market, by End User
- 9.1. Introduction
- 9.2. Academic & Research Institutes
- 9.3. Contract Research Organizations
- 9.4. Pharmaceutical & Biotechnology Companies
- 10. Americas High-Throughput Screening Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific High-Throughput Screening Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa High-Throughput Screening Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. Merger & Acquisition
- 13.3.1.1. Charles River Laboratories Acquires SAMDI Tech
- 13.3.2. Agreement, Collaboration, & Partnership
- 13.3.2.1. Axxam And Promega Announce Agreement To Develop Smart Assays For Drug Discovery Services
- 13.3.3. New Product Launch & Enhancement
- 13.3.3.1. Particle Works Launches ALiS – An Automated and High-Throughput Platform for LNP Formulation Screening
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Agilent Technologies, Inc.
- 14.1.2. Aurora Biomed Inc.
- 14.1.3. AXXAM S.p.A.
- 14.1.4. Beckman Coulter, Inc.
- 14.1.5. Bio-Rad Laboratories, Inc.
- 14.1.6. BMG LABTECH GmbH
- 14.1.7. Charles River Laboratories International, Inc.
- 14.1.8. Corning Incorporated
- 14.1.9. Danaher Corporation
- 14.1.10. DIANA Biotechnologies, a.s.
- 14.1.11. Eurofins Scientific SE
- 14.1.12. F. Hoffmann-La Roche AG
- 14.1.13. Hamilton Company
- 14.1.14. IRBM S.p.A.
- 14.1.15. Lonza Group AG
- 14.1.16. Luminex Corporation
- 14.1.17. Merck KGaA
- 14.1.18. Molecular Devices, LLC
- 14.1.19. NanoTemper Technologies GmbH
- 14.1.20. PerkinElmer, Inc.
- 14.1.21. Promega Corporation
- 14.1.22. Reprocell Inc.
- 14.1.23. SYGNATURE DISCOVERY LIMITED
- 14.1.24. Tecan Trading AG
- 14.1.25. Thermo Fisher Scientific Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook